UCB to Invest $2B in Atlanta Drug Plant, Creating 330 Jobs
Belgian pharmaceutical company UCB will invest $2 billion to build a major drug manufacturing facility in suburban Atlanta, creating approximately 330 high-paying jobs and expanding its U.S. presence.


